Newer prophylactic agents for bipolar disorder and their influence on suicidality

Archives of Suicide Research

Volumn 9, Issue 3, 2005, Pages 301-306

  Born, Christoph ^a   Dittmann, Sandra ^a   Post, Robert M ^a   Grunze, Heinz ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Anticonvulsives; Bipolar disorder; Lithium

Indexed keywords

TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR DISORDER; FEMALE; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; SUICIDE; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SUICIDE; SUICIDE, ATTEMPTED; TREATMENT OUTCOME;

EID: 22144434416     PISSN: 13811118     EISSN: 15436136     Source Type: Journal    
DOI: 10.1080/13811110590929541     Document Type: Article

References (27)

1. Ahrens, B., Müller-Oerlinghausen, B., Schou, M. et al. (1995). Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. Journal of Affective Disorders, 33, 67-75.
2. Althaus, D. & Hegerl, U. (2003). The evaluation of suicide prevention activities: State of the art. World Journal of Biological Psychiatry, 4, 156-165.
3. Angst, J. & Gamma, A. (2002). A new bipolar spectrum concept: A brief review. Bipolar disorders, 4 (Suppl 1), 11-14.
4. Apter, A., van Praag, H. M., Plutchik, R. et al. (1990). Interrelationships among anxiety, aggression, impulsivity, and mood: A serotonergically linked duster? Psychiatry Research, 32, 191-199.
5. Baldessarini, R. J. & Tondo, L. (2003). Suicide risk and treatment for patients with bipolar disorder. Journal of the American Medical Association, 290, 1517-1519.
6. Biggs, M. M., Shores-Wilson, K., Rush, A. J. et al. (2000). A comparison of alternative assessments of depressive symptom severity: A pilot study. Psychiatry Research, 96, 269-279.
7. Bostwick, J. M. & Pankratz, V. S. (2000). Affective disorder and suicide risk: A reexamination. American Journal of Psychiatry, 157, 1925-1932.
8. Coppen, A., Standish-Barry, H., Bailey, J., et al. (1991). Does lithium reduce the mortality of recurrent mood disorders? Journal of Affective Disorders, 23, 1-7.
9. Dittmann, S., Biedermann, N. C., Grunze, H. et al. (2002). The Stanley Foundation Bipolar Network: Results of the naturalistic follow-up study (NFS) after 21/2 years of follow-up in the German centres. Neuropsychobiology, 46, (Suppl 1), 2-9.
10. Felber, W. & Kyber, A. (1994). Suizide und Parasuizide während und außerhalb einer Lithiumprophylaxe. In B. Müller-Oerlinghausen & A. Berghoefer (Eds.), Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen, (pp. 53-59). Stuttgart Thieme.
11. Goodwin, F. K., Fireman, B., Simon, G. E. et al. (2003). Suicide risk in bipolar disorder during treatment with lithium and divalproex. The Journal of the American Medical Association (JAMA), 290(11), 1467-1473.
12. Goodwin, G. M. (2003). Evidence-based guidelines for treating bipolar disorder Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 17, 149-173.
13. Ketter, T. A. & Calabrese, J. R. (2002). Stabilisation of mood from below versus above baseline in bipolar disorder A new nomenclature. Journal of Clinical Psychiatry, 63, 146-151.
14. Lapierre, Y. D. (2003). Suicidality with selective serotonin reuptake inhibitors: Valid claim? Journal of Psychiatry and Neuroscience, 28, 340-347.
15. Leverich, G. S., Altshuler, L. L., Frye, M. A. et al. (2003). Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. Journal of Clinical Psychiatry, 64, 506-515.
16. Leverich, G. S., Nolen, W. A., Rush, A. J. et al. (2001). The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. Journal of Affective Disorders, 67, 33-44.
17. Müller-Oerlinghausen, B. (2001). Arguments for the specificity of the anti-suicidal effect of lithium. European Archives of Psychiatry Clinical Neuroscience, 251, (Suppl 2) II72-II75.
18. Müller-Oerlinghausen, B., Ahrens, B., Grof, E. et al. (1992). The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizo-affective illness. Acta Psychiatrica Scandinavica, 86, 218-222.
19. Müller-Oerlinghausen, B. & Berghöfer, A. (1999). Antidepressants and suicidal risk. Journal of Clinical Psychiatry, 60 (Suppl 2), 94-99.
20. Müller-Oerlinghausen, B., Muser-Causemann, B., & Volk, J. (1992). Suicides and para-suicides in a high-risk patient group on and off lithium long-term medication. Journal of Affective Disorders, 25, 261-269.
21. Nilsson, A. (1995). Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients. Pharmacopsychiatry, 28, 8-13.
22. Nilsson, A. (1999). Lithium therapy and suicide risk. Journal of Clinical Psychiatry, 60 (Suppl 2), 85-8; discussion 111-6, 85-88.
23. Rush, A. J., Giles, D. E., Schlesser, M. A. et al. (1986). The Inventory for Depressive Symptomatology (IDS): Preliminary findings. Psychiatry Research, 18, 65-87.
24. Thies-Flechtner, K., Müller-Oerlinghausen, B., Seibert, W. et al. (1996). Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomised prospective trial. Pharmacopsychiatry, 29, 103-107.
25. van Praag, H. M. (1992). About the centrality of mood lowering in mood disorders. Plenary Lecture ECNP Congress, Monte Carlo, October 1991. European Neuropsychopharmacology, 2, 393-404.
26. Wegerer, J. V., Hesslinger, B., Berger, M. et al. (1997). A calcium antagonistic effect of the new anti-epileptic drug lamotrigine. European Neuropsychopharmacology, 7, 77-81.
27. Yerevanian, B. I., Koek, R. J., & Mintz, J. (2003). Lithium, anti-convulsants and suicidal behaviour in bipolar disorder. Journal of Affective Disorders, 73, 223-228.